CrowdStrike Holdings, Inc.
CrowdStrike is executing well and growing into a larger platform, but at $237.65 the stock prices in years of near-flawless AI-led growth despite a 44.8x sales multiple, 6751.42x P/E, and a quant base value of $97.23.
CrowdStrike is doing almost everything right operationally, and that is exactly why the stock is dangerous here. The company closed FY2026 with $4.8B of revenue, up 20.4% YoY, and management is guiding FY27 revenue to $5.868B-$5.928B with ARR at $6.466B-$6.516B. Q4 was strong by any fair standard: $330.7M of net new ARR, $1.31B of revenue, $325.8M of operating income, and $376.4M of free cash flow. The problem is not the business. The problem is paying a price that assumes this pace persists with minimal competition, minimal integration friction, and continued investor willingness to fund one of the richest software multiples in the market.
At $237.65, investors are paying 44.8x sales, 47.38x book, and a trailing 6751.42x P/E for a company that still posted -$0.16 of FY2026 GAAP EPS and a -3.0% operating margin. Even using management's FY27 non-GAAP EPS guide of $4.78-$4.90, the stock still sits around roughly 48x-50x forward earnings. That is not impossible for a category leader, but it leaves little room for normal software deceleration. ARR growth of 23%-24% is good. It is just not the kind of growth that normally protects a $242.0B market cap from multiple compression.
The bull case rests on three things. First, Falcon remains a real platform, not just a single-product story, with Cloud, Next-Gen Identity, and Next-Gen SIEM at $1.9B ARR, up more than 45% YoY. Second, AI appears to be helping now, with management citing 49% YoY pipeline growth and saying, "As AI adoption accelerates, combined with our record Q1 pipeline and continued platform consolidation momentum, we have strong conviction to once again raise our FY '27 ARR outlook." Third, management has a clean execution record, beating EPS in 8 consecutive quarters.
What keeps conviction from going high is simple. Great businesses can still be bad stocks at the wrong price. The stock is 5.1% below its all-time high, 61.7% above the 200-day average, and short interest is only 2.43%, so positioning does not offer much protection if expectations cool. A better entry would require either a substantial price reset or evidence that CrowdStrike can turn this ARR base into durable GAAP profitability fast enough to justify the current premium.
Pipeline conversion stays very strong, AI and Flex drive another year of ARR upside, and investors continue to pay a premium for category leadership despite the rich multiple.
Execution stays solid but not exceptional enough to sustain the current premium, and valuation compresses toward a level better aligned with 23%-24% ARR growth.
Growth cools toward high teens, AI enthusiasm fades, and the market cuts the sales multiple sharply from 44.8x as investors refocus on thin GAAP profitability.
Quant call (SELL) diverges from analyst consensus (Strong Buy: 29 buy / 8 hold / 0 sell) — resolve explicitly.
The market is like a large movie theater with a small door.
Forward earnings power is improving, with FY27 non-GAAP EPS guided to $4.78-$4.90, but against a $237.65 stock that still implies a forward non-GAAP P/E around the high-40s to roughly 50x, and the trailing GAAP P/E is effectively unusable at 6751.42x. The moat is stronger today than two years ago because Falcon is broadening into cloud, identity, SIEM, and marketplace distribution, but over 3-5 years the question is whether AI becomes a durable data advantage for CrowdStrike or compresses differentiation as hyperscalers and platform suites embed more security natively. AI is currently a tailwind because management is seeing Flex and AI demand lift pipeline 49% YoY, yet the stock already prices in that tailwind continuing with very little friction. Regulation and rising security complexity support TAM growth, but at this valuation the debate is no longer whether CrowdStrike wins, it is whether it wins enough to justify an enterprise value that leaves little room for slower growth or margin disappointment.
- Valuation is extreme at 44.8x P/S versus 12.5x peers and 6751.42x P/E versus 41.0x peer average.
- FY27 guidance remains strong, with revenue of $5.868B-$5.928B and ARR of $6.466B-$6.516B, but that still implies growth that is decelerating versus prior hyper-growth phases.
- Price action is stretched, with the stock -5.1% from the $250.32 high and 61.7% above the $146.97 200-day average after a 40.07% move in 3 months.
- Management just posted a strong quarter, including $330.7M net new ARR, $1.31B revenue, $325.8M operating income, and $376.4M FCF, all ahead of guided levels.
- FY27 demand indicators are real, not cosmetic: management cited record Q1 pipeline growth of 49% YoY and raised FY27 ARR outlook to $6.466B-$6.516B.
- Higher-value platforms are scaling fast, with Cloud, Next-Gen Identity, and Next-Gen SIEM at $1.9B ARR, up more than 45% YoY, which supports platform depth beyond core endpoint.
- Cash generation is healthy despite GAAP noise, with FY27 free cash flow margin guided to at least 30% and FY2026 FCF at $0.4B against just $0.1B of capex.
- The stock already discounts an aggressive future, trading at 44.8x sales and 47.38x book while FY2026 GAAP EPS was -$0.16 and operating margin was -3.0%.
- Peer-based valuation support is weak: the quant engine uses 7 peers with average P/E 41.0, but dispersion is a very wide 4.8x, making comparables less reliable and underscoring how far CRWD sits from normal software valuation anchors.
- FY27 operating help is flattered by accounting, because sales commission amortization shifts from 4 to 5 years starting Q1 FY27, while acquisitions add $74M-$80M of operating expense.
- Recent M&A contributes only modestly near term, with $5M-$8M acquired net new ARR in Q1 and only minimal organic contribution from the acquisitions beyond acquired ARR.
| Metric | Value | Context |
|---|---|---|
| Current price | $237.65 | Reference price for valuation and scenario framing |
| Quant price target | $97.23 | -59.1% vs current, Low confidence, basis: earnings_growth_blend |
| FY2026 revenue | $4.8B | Grew 20.4% YoY |
| FY2026 EPS | -$0.16 | Down 112.5% YoY, helps explain unusable trailing P/E |
| Operating margin | -3.0% | Flat versus prior FY, still weak on a GAAP basis |
| Free cash flow | $0.4B | Positive cash generation with $0.1B capex |
| Valuation, P/E | 6751.42x | Versus peer average 41.0x |
| Valuation, P/S | 44.8x | Versus peer average 12.5x |
| FY27 revenue guide | $5.868B-$5.928B | Management outlook after strong Q4 |
| FY27 ARR guide | $6.466B-$6.516B | Implies 23%-24% YoY ARR growth |
| FY27 non-GAAP EPS guide | $4.78-$4.90 | Improving earnings power, but still expensive against current price |
| 52-week position | -5.1% vs $250.32 high | Also 61.7% above the $146.97 200-day average |
The biggest risk to a bearish stance is that AI-led consolidation keeps ARR compounding above the 23%-24% FY27 guide for longer than expected, allowing an expensive stock to stay expensive.
The next key catalyst is the December 1, 2026 earnings report, especially whether Q1 FY27 ARR lands above the $5.502B-$5.504B guide and whether management raises the $6.466B-$6.516B FY27 ARR outlook again.
Positioning looks crowded rather than washed out. The stock is 5.1% below its 52-week high, short interest is only 2.43% with 2.1 days-to-cover, and the options setup is in a positive gamma regime with zero-gamma at $224.98, which usually dampens downside volatility unless a catalyst breaks the range. Low short interest means there is not much fuel for a squeeze, while momentum ownership can reverse hard if growth merely meets, rather than beats, high expectations.
Grew 20.4% YoY, with FY27 revenue guided to $5.868B-$5.928B.
These adjacencies grew more than 45% YoY and are the clearest proof that the platform is expanding beyond endpoint.
Recurring revenue remains the core economic engine and the best read on future monetization.
No geographic revenue split was supplied, so the read must rely on company-wide demand indicators and channel comments such as enterprise, down-market, and MSSP strength.
CrowdStrike delivered a blockbuster Q4 and raised FY27 ARR outlook on strong Flex and AI demand.
Management has earned credibility on near-term delivery. Since the historical 2025 Q1 call, CrowdStrike beat EPS in 8 straight quarters, from +14.8% in 2024-11-26 to +6.3% on 2026-08-26, and the company moved from FY25 revenue guidance of $3.9763B-$4.0107B to actual FY2026 revenue of $4.8B, while extending the platform story through Flex, AI, and larger-module adoption. The strategic direction has stayed consistent: two years ago management stressed consolidation demand, larger module counts, and Flex adoption, and today those themes show up in $330.7M net new ARR, 49% YoY Q1 pipeline growth, and the $1.9B ARR cloud, identity, and SIEM bucket. The caveat is that some FY27 margin help comes from the commission amortization change from 4 to 5 years, so execution is strong, but not all of the optical margin improvement is purely operational.
As AI adoption accelerates, combined with our record Q1 pipeline and continued platform consolidation momentum, we have strong conviction to once again raise our FY '27 ARR outlook.
For the first quarter of FY '27, we expect annual recurring revenue to be in the range of $5.502 billion to $5.504 billion, inclusive of the estimated acquired ARR and reflecting a year-over-year growth rate of 24%, translating to net new ARR of $249 million to $251 million, reflecting a year-over-year growth rate of 29% to 30%.
For the full fiscal year 2027, we expect annual recurring revenue to be in the range of $6.466 billion to $6.516 billion, reflecting a year-over-year growth rate of 23% to 24% and translating to net new ARR of $1.213 billion to $1.264 billion, reflecting a year-over-year growth rate of 20% to 25%.
FY '26 was CrowdStrike's best year yet capped by a blockbuster Q4 where we set new records across the business.
Our strong business momentum and Q1 record pipeline entering FY '27, which grew 49% year-over-year, gives us conviction in our ability to deliver profitable growth throughout FY '27 and beyond.
CrowdStrike's moat comes from a scaled security data layer, a broad Falcon module set, and platform consolidation economics that let customers replace multiple point products. The moat looks real today because the company is still landing larger platform deals, Flex has gained traction, and cloud, identity, and SIEM reached $1.9B ARR growing more than 45% YoY. Durability is good but not impregnable, because hyperscalers, Palo Alto, Microsoft, and other integrated platforms are all investing heavily in AI-driven security workflows.
Capital allocation is conservative and mostly organic. FY2026 free cash flow was $0.4B with just $0.1B of capex, there were no buybacks and no dividend, and management is using the balance sheet for selective tuck-in acquisitions such as SGNL.ai and Seraphic rather than financial engineering. That is sensible, but at this valuation the highest-return use of capital would need to show clear ARR and platform synergies quickly.
CrowdStrike is a high-quality cybersecurity platform with real AI and consolidation tailwinds, but the stock is priced for near perfection. Rated SELL, Medium conviction because the business can remain excellent while the shares still disappoint from $237.65. The key issue is not whether CrowdStrike wins customers, it is whether that win is enough to support 44.8x sales and a $242.0B market cap. A rating change would require either a much lower entry point or proof that GAAP profitability and cash earnings can scale materially faster than the current valuation already assumes.
≣ Full research note tap to expand
Executive Summary
SELL, Medium conviction. Rated SELL, Medium conviction. The operating story is strong, with FY27 revenue guided to $5.868B-$5.928B, ARR to $6.466B-$6.516B, and free cash flow margin at at least 30%, but the stock sits 5.1% below its 52-week high and 61.7% above its 200-day average, leaving little room for any slip. This is not a broken company, it is an overowned, richly priced winner where fundamentals are good and the entry price is not.
Investment Thesis
CrowdStrike is doing almost everything right operationally, and that is exactly why the stock is dangerous here. The company closed FY2026 with $4.8B of revenue, up 20.4% YoY, and management is guiding FY27 revenue to $5.868B-$5.928B with ARR at $6.466B-$6.516B. Q4 was strong by any fair standard: $330.7M of net new ARR, $1.31B of revenue, $325.8M of operating income, and $376.4M of free cash flow. The problem is not the business. The problem is paying a price that assumes this pace persists with minimal competition, minimal integration friction, and continued investor willingness to fund one of the richest software multiples in the market.
At $237.65, investors are paying 44.8x sales, 47.38x book, and a trailing 6751.42x P/E for a company that still posted -$0.16 of FY2026 GAAP EPS and a -3.0% operating margin. Even using management's FY27 non-GAAP EPS guide of $4.78-$4.90, the stock still sits around roughly 48x-50x forward earnings. That is not impossible for a category leader, but it leaves little room for normal software deceleration. ARR growth of 23%-24% is good. It is just not the kind of growth that normally protects a $242.0B market cap from multiple compression.
The bull case rests on three things. First, Falcon remains a real platform, not just a single-product story, with Cloud, Next-Gen Identity, and Next-Gen SIEM at $1.9B ARR, up more than 45% YoY. Second, AI appears to be helping now, with management citing 49% YoY pipeline growth and saying, "As AI adoption accelerates, combined with our record Q1 pipeline and continued platform consolidation momentum, we have strong conviction to once again raise our FY '27 ARR outlook." Third, management has a clean execution record, beating EPS in 8 consecutive quarters.
What keeps conviction from going high is simple. Great businesses can still be bad stocks at the wrong price. The stock is 5.1% below its all-time high, 61.7% above the 200-day average, and short interest is only 2.43%, so positioning does not offer much protection if expectations cool. A better entry would require either a substantial price reset or evidence that CrowdStrike can turn this ARR base into durable GAAP profitability fast enough to justify the current premium.
Key Metrics
| Metric | Value | Context |
|---|---|---|
| Current price | $237.65 | Reference price for valuation and scenario framing |
| Quant price target | $97.23 | -59.1% vs current, Low confidence, basis: earnings_growth_blend |
| FY2026 revenue | $4.8B | Grew 20.4% YoY |
| FY2026 EPS | -$0.16 | Down 112.5% YoY, helps explain unusable trailing P/E |
| Operating margin | -3.0% | Flat versus prior FY, still weak on a GAAP basis |
| Free cash flow | $0.4B | Positive cash generation with $0.1B capex |
| Valuation, P/E | 6751.42x | Versus peer average 41.0x |
| Valuation, P/S | 44.8x | Versus peer average 12.5x |
| FY27 revenue guide | $5.868B-$5.928B | Management outlook after strong Q4 |
| FY27 ARR guide | $6.466B-$6.516B | Implies 23%-24% YoY ARR growth |
| FY27 non-GAAP EPS guide | $4.78-$4.90 | Improving earnings power, but still expensive against current price |
| 52-week position | -5.1% vs $250.32 high | Also 61.7% above the $146.97 200-day average |
Financial Strength
The balance sheet is acceptable, not pristine. Debt looks manageable with 0.16 debt/equity and $0.8B total debt, though 4.49x debt/EBITDA is not trivial for a company still showing -3.0% operating margin and -0.5% net margin on a GAAP basis. The key support is cash generation: FY2026 free cash flow of $0.4B, Q4 FCF of $376.4M, low capex at $0.1B, and FY27 FCF margin guided to at least 30%. That said, margin interpretation needs discipline because part of the FY27 operating lift comes from moving sales commission amortization from 4 to 5 years, not just from core operating leverage.
Competitive Position
CrowdStrike's moat comes from a scaled security data layer, a broad Falcon module set, and platform consolidation economics that let customers replace multiple point products. The moat looks real today because the company is still landing larger platform deals, Flex has gained traction, and cloud, identity, and SIEM reached $1.9B ARR growing more than 45% YoY. Durability is good but not impregnable, because hyperscalers, Palo Alto, Microsoft, and other integrated platforms are all investing heavily in AI-driven security workflows.
Management & Guidance
Management's FY27 guide is strong and, based on the record, reasonably credible. The company is guiding Q1 FY27 ARR to $5.502B-$5.504B, Q1 revenue to $1.360B-$1.364B, and FY27 revenue to $5.868B-$5.928B, with FY27 non-GAAP EPS of $4.78-$4.90. Credibility comes from repeated beats, including 8 straight EPS beats, and from hard demand markers like 49% YoY pipeline growth and raised ARR outlook after a quarter that exceeded guidance on revenue, operating income, and free cash flow. The main adjustment for investors is that some margin upside is accounting-driven, and the acquisitions add $74M-$80M of FY27 operating expense while contributing only $5M-$8M of Q1 acquired net new ARR.
Segment Analysis
- Total company revenue ($4.8B FY2026): Grew 20.4% YoY, with FY27 revenue guided to $5.868B-$5.928B.
- Cloud + Next-Gen Identity + Next-Gen SIEM ($1.9B ARR): These adjacencies grew more than 45% YoY and are the clearest proof that the platform is expanding beyond endpoint.
- ARR base (Q1 FY27 guide $5.502B-$5.504B, FY27 guide $6.466B-$6.516B): Recurring revenue remains the core economic engine and the best read on future monetization.
- Geography (Not disclosed in the provided data): No geographic revenue split was supplied, so the read must rely on company-wide demand indicators and channel comments such as enterprise, down-market, and MSSP strength.
Capital Allocation
Capital allocation is conservative and mostly organic. FY2026 free cash flow was $0.4B with just $0.1B of capex, there were no buybacks and no dividend, and management is using the balance sheet for selective tuck-in acquisitions such as SGNL.ai and Seraphic rather than financial engineering. That is sensible, but at this valuation the highest-return use of capital would need to show clear ARR and platform synergies quickly.
Management Execution & Track Record
Management has earned credibility on near-term delivery. Since the historical 2025 Q1 call, CrowdStrike beat EPS in 8 straight quarters, from +14.8% in 2024-11-26 to +6.3% on 2026-08-26, and the company moved from FY25 revenue guidance of $3.9763B-$4.0107B to actual FY2026 revenue of $4.8B, while extending the platform story through Flex, AI, and larger-module adoption. The strategic direction has stayed consistent: two years ago management stressed consolidation demand, larger module counts, and Flex adoption, and today those themes show up in $330.7M net new ARR, 49% YoY Q1 pipeline growth, and the $1.9B ARR cloud, identity, and SIEM bucket. The caveat is that some FY27 margin help comes from the commission amortization change from 4 to 5 years, so execution is strong, but not all of the optical margin improvement is purely operational.
Positioning & Flows
Positioning looks crowded rather than washed out. The stock is 5.1% below its 52-week high, short interest is only 2.43% with 2.1 days-to-cover, and the options setup is in a positive gamma regime with zero-gamma at $224.98, which usually dampens downside volatility unless a catalyst breaks the range. Low short interest means there is not much fuel for a squeeze, while momentum ownership can reverse hard if growth merely meets, rather than beats, high expectations.
Bull Case
- Management just posted a strong quarter, including $330.7M net new ARR, $1.31B revenue, $325.8M operating income, and $376.4M FCF, all ahead of guided levels.
- FY27 demand indicators are real, not cosmetic: management cited record Q1 pipeline growth of 49% YoY and raised FY27 ARR outlook to $6.466B-$6.516B.
- Higher-value platforms are scaling fast, with Cloud, Next-Gen Identity, and Next-Gen SIEM at $1.9B ARR, up more than 45% YoY, which supports platform depth beyond core endpoint.
- Cash generation is healthy despite GAAP noise, with FY27 free cash flow margin guided to at least 30% and FY2026 FCF at $0.4B against just $0.1B of capex.
Bear Case
- The stock already discounts an aggressive future, trading at 44.8x sales and 47.38x book while FY2026 GAAP EPS was -$0.16 and operating margin was -3.0%.
- Peer-based valuation support is weak: the quant engine uses 7 peers with average P/E 41.0, but dispersion is a very wide 4.8x, making comparables less reliable and underscoring how far CRWD sits from normal software valuation anchors.
- FY27 operating help is flattered by accounting, because sales commission amortization shifts from 4 to 5 years starting Q1 FY27, while acquisitions add $74M-$80M of operating expense.
- Recent M&A contributes only modestly near term, with $5M-$8M acquired net new ARR in Q1 and only minimal organic contribution from the acquisitions beyond acquired ARR.
Valuation & Price Target
Engine price target $97.23 (-59.1% vs current), Low confidence.
- P/E Multiple: $1.15 (0% weight)
- PEG (growth-adjusted): $1.08 (20% weight)
- P/S Multiple: $59.07 (12% weight)
- Quality-adjusted: $237.84 (20% weight)
- DCF: $5.56 (4% weight)
This rating aligns with the quant baseline SELL, but with Medium rather than low conviction because the operating business is objectively strong. The quant target of $97.23 is directionally credible given the valuation stack: 44.8x P/S versus 12.5x peers, 6751.42x P/E versus 41.0x peers, and the engine's blended methods showing only $59.07 from P/S, $5.56 from DCF, and $1.15 from P/E, with only the quality-adjusted method near the current price at $237.84. That split captures the setup well: quality and execution are real, but the stock already capitalizes most of that quality. Sell-side consensus remains Strong Buy, 29 buy / 8 hold / 0 sell, but that is low-signal context here and not persuasive against the math of valuation compression risk at a $242.0B market cap.
Risk Assessment
Risk score 46/100 (Moderate). The biggest risk to a bearish stance is that AI-led consolidation keeps ARR compounding above the 23%-24% FY27 guide for longer than expected, allowing an expensive stock to stay expensive.
The Bottom Line
CrowdStrike is a high-quality cybersecurity platform with real AI and consolidation tailwinds, but the stock is priced for near perfection. Rated SELL, Medium conviction because the business can remain excellent while the shares still disappoint from $237.65. The key issue is not whether CrowdStrike wins customers, it is whether that win is enough to support 44.8x sales and a $242.0B market cap. A rating change would require either a much lower entry point or proof that GAAP profitability and cash earnings can scale materially faster than the current valuation already assumes.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr